Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
XTL Biopharmaceuticals Ltd ADR
XTLBCurrent price
1.14 USD
+0.012 USD (+1.06%)
Last closed
1.17 USD
Company
www.xtlbio.com
ISIN
US98386D3070
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
9 099 930 USD
Yield for 12 month
-59.36 %
1Y
3Y
5Y
10Y
15Y
XTLB
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel. Address: 26 Ben-Gurion St., Ramat Gan, Israel, 5112001
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
-459 000 USD
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-460 000 USD
Current Quarter
–
Last Quarter
–
Key Figures XTLB
1 year
3 years
5 years
10 years
EBITDA
-764 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-13.78 %
PEG Ratio
–
Return On Equity TTM
-13.07 %
Wall Street Target Price
30.00 USD
Revenue TTM
–
Book Value
0.0050 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.030 USD
Diluted Eps TTM
-0.030 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
-76.00 %
Profit Margin
–
Dividend Analytics XTLB
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History XTLB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
10.02.2017
Stock Valuation XTLB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
9.35
Price Book MRQ
3.36
Financials XTLB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XTLB
For 52 weeks
0.76 USD
4.99 USD
50 Day MA
1.91 USD
Shares Short Prior Month
75 243
200 Day MA
2.31 USD
Short Ratio
3.35
Shares Short
74 955
Short Percent
1.02 %
BeatStart